Clinical trial
A Phase I/II Trial of D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer - The AIO-MEFOX Trial (AIO-KRK-0119)
NCT05212012 is registered in ClinicalTrials.gov with AIO-Studien-gGmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer - The AIO-MEFOX Trial (AIO-KRK-0119)
- Lead sponsor
- AIO-Studien-gGmbH
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- February 17, 2022
- Completion date
- December 31, 2025
- Enrollment
- 11 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chemo-refractory colorectal carcinoma